Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis
Chelsey Foster, Jad Baki, Samantha Nikirk, Sydni Williams, Neehar D. Parikh, Elliot B. Tapper – 2 April 2020 – Cost‐effectiveness analysis depends on generalizable health‐state utilities. Unfortunately, the available utilities for cirrhosis are dated, may not reflect contemporary patients, and do not capture the impact of cirrhosis symptoms. We aimed to determine health‐state utilities for cirrhosis, using both the standard gamble (SG) and visual analog scale (VAS). We prospectively enrolled 305 patients.